MRNA - These 2 Robinhood Favorites Could Double by 2022
The stock market rewards patience. Parking your money in securities with solid prospects and a strong competitive advantage is a great strategy for yielding substantial results over longer periods of time. But for some stocks, doubling in value in just a year is a real possibility. Investors should remember, though, that these tend to be high-risk, high-reward plays.
With that disclaimer out of the way, here are two companies whose shares could skyrocket within the next 12 months: Moderna (NASDAQ: MRNA) and Sorrento Therapeutics (NASDAQ: SRNE) . Both are on the list of the 100 most popular stocks on the commission-free trading platform Robinhood. If you have a higher-than-average risk tolerance, find out why these stocks could double your money between now and 2022.
For further details see:
These 2 Robinhood Favorites Could Double by 2022